
Chembio Diagnostics CEMI
Annual report 2022
added 03-29-2023
Chembio Diagnostics Total Shareholders Equity 2011-2026 | CEMI
Annual Total Shareholders Equity Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8 M | 34.3 M | 27.8 M | 24 M | 33.3 M | 13.1 M | 17.2 M | 17.7 M | 19.7 M | 20.2 M | 13.9 M | 12.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.3 M | 12.5 M | 20.9 M |
Quarterly Total Shareholders Equity Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 17.8 M | 19.9 M | 26.5 M | 34.3 M | 47.9 M | 15.1 M | 23.3 M | 27.8 M | 27.8 M | 27.8 M | 27.8 M | 24 M | 24 M | 24 M | 24 M | 33.3 M | 33.3 M | 33.3 M | 33.3 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.9 M | 12.5 M | 20.9 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 17.35 | -6.52 % | $ 183 M | ||
|
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
20.6 M | $ 1.46 | -10.44 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
471 M | $ 19.26 | 1.99 % | $ 558 M | ||
|
Fulgent Genetics
FLGT
|
1.13 B | $ 16.02 | -1.05 % | $ 484 M | ||
|
Agilent Technologies
A
|
5.39 B | $ 112.14 | -0.98 % | $ 34.1 B | ||
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
2.37 B | $ 140.19 | -2.13 % | $ 22.3 B | ||
|
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
22.4 M | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
303 M | $ 20.04 | -2.22 % | $ 1.07 B | ||
|
Lantheus Holdings
LNTH
|
1.09 B | $ 94.57 | -2.18 % | $ 6.38 B | ||
|
Check-Cap Ltd.
CHEK
|
3.44 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
459 M | $ 420.05 | 0.21 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 048.98 | 0.68 % | $ 21.6 B | ||
|
Myriad Genetics
MYGN
|
368 M | $ 3.62 | - | $ 335 M | ||
|
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
837 M | $ 8.3 | -0.72 % | $ 1.06 B | ||
|
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
3.16 B | $ 158.51 | -0.5 % | $ 7.86 B | ||
|
National Research Corporation
NRC
|
14 M | $ 19.0 | 0.37 % | $ 425 M | ||
|
Natera
NTRA
|
706 M | $ 185.77 | -5.66 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
11 B | $ 25.23 | -1.1 % | $ 23.9 B | ||
|
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | ||
|
Senseonics Holdings
SENS
|
61 M | $ 5.84 | 0.34 % | $ 244 M | ||
|
Guardant Health
GH
|
-99.3 M | $ 95.26 | -3.45 % | $ 11.9 B | ||
|
Personalis
PSNL
|
261 M | $ 6.46 | -3.73 % | $ 576 M | ||
|
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
9.52 B | $ 118.21 | 0.96 % | $ 9.75 B | ||
|
Soleno Therapeutics
SLNO
|
450 M | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
473 M | $ 49.69 | -6.16 % | $ 2.97 B | ||
|
Biomerica
BMRA
|
4.1 M | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 251.84 | -0.89 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
53.4 B | $ 441.44 | -1.5 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
-35.2 M | $ 0.59 | 1.42 % | $ 212 M | ||
|
Celcuity
CELC
|
101 M | $ 132.6 | -1.57 % | $ 6.2 B | ||
|
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
2.56 B | $ 332.1 | -0.33 % | $ 19.8 B | ||
|
Neogen Corporation
NEOG
|
2.07 B | $ 8.36 | -0.83 % | $ 1.81 B |